Lab-Grown Food Market Moves Toward Commercialization as Cell-Based Production, Bioreactors and Regulatory Approvals Advance

The global Lab-Grown Food Market is moving from experimental development toward early commercial adoption as advances in cellular agriculture, bioreactor technology and food-safety regulation create new pathways for cultivated products. Next Move Strategy Consulting identifies 2024 as the base year and 2025–2030 as the forecast period, with the market spanning cultured meat, dairy alternatives, lab-grown eggs, gelatin and collagen, and other emerging products. The research points to urbanization, biotechnology investment and advances in production technology as important growth factors, while high production costs remain a central challenge.

View the Lab-Grown Food Market report from Next Move Strategy Consulting

Request the FREE Sample Here

Market Growth and Outlook

Lab-grown food broadly encompasses products developed through controlled biological processes rather than conventional agricultural production. In the cultivated-meat segment, animal cells are grown under controlled conditions and can subsequently be incorporated into food products. The approach is being investigated across beef, chicken, pork and seafood, while related technologies are being applied to dairy proteins, eggs, gelatin and collagen.

The publicly available Next Move Strategy Consulting report does not disclose numerical market-size, forecast-value or CAGR figures on its current report page, displaying placeholders instead. Accordingly, no unsupported valuation or growth rate is included in this release. The study nevertheless provides a 2025–2030 forecast framework and identifies the technologies, product categories, regional markets, growth drivers and constraints shaping the sector.

The development trajectory is increasingly being influenced by real-world regulatory decisions. On June 18, 2025, Food Standards Australia New Zealand (FSANZ) gazetted changes to permit cell-cultured quail as a food in Australia and New Zealand. FSANZ said its assessment found no toxicological, nutritional or allergenic concerns and determined that microbiological risks could be managed through established food-safety controls.

Singapore has also established an early regulatory pathway. The Singapore Food Agency requires novel alternative proteins without a history of safe consumption to undergo pre-market safety assessment, including consideration of toxicity, allergenicity, production methods and dietary exposure. Eat Just’s cultured chicken was approved for use as an ingredient in Singapore following scientific assessment.

Key Market Drivers

Urbanization and land constraints are identified by Next Move Strategy Consulting as important market drivers. As populations become increasingly concentrated in cities, food producers face greater pressure to improve production efficiency and develop systems that are less dependent on conventional agricultural land. The report cites United Nations population trends in support of the long-term urbanization argument.

Biotechnology investment is another contributor. The market report highlights public investment in industrial biotechnology and bioprocess engineering as a mechanism supporting research, process development and commercialization. It specifically points to investment initiatives in the United Kingdom and Japan that are strengthening the broader biotechnology ecosystem.

Demand for alternative protein options is also encouraging experimentation with cellular agriculture. FAO and WHO have examined food-safety aspects of cell-based foods, recognizing the technology as an emerging method for producing animal-derived foods through cell cultures and emphasizing the need for science-based risk assessment.

Technological improvements in cell cultivation and bioprocessing are central to the industry’s progress. Better control of cells, nutrient delivery, bioreactors and product structuring could help companies improve consistency and eventually reduce production costs.

Emerging Market Trends

A major development is the transition from laboratory experimentation to regulated commercial food products. Australia and New Zealand’s approval of cultured quail demonstrates that products can progress through formal food-safety assessment and enter regulated markets when evidence requirements are satisfied.

Bioreactor-based cultivation is becoming increasingly important as companies seek scalable production systems. Next Move Strategy Consulting identifies scaffold-based, suspension-based and bioreactor-based cultivation as key production approaches. These technologies address different challenges involving cell growth, structure, scale and final product characteristics.

3D bioprinting and advanced food structuring represent another emerging opportunity. The Next Move Strategy Consulting report identifies 3D bioprinting as a technology capable of helping reproduce the texture, flavor profile and nutritional characteristics of conventional foods, potentially improving consumer acceptance.

Regulatory science and labeling are also becoming more important. In the European Union, novel foods must undergo authorization and scientific safety assessment before commercialization, while EFSA evaluates potential risks including toxicity, allergenicity and nutritional characteristics. EFSA notes that cell culture-derived animal foods remain an emerging category and that no animal-origin cell-culture food had been approved for sale in the EU as of its December 2025 review.

Finally, cost reduction and scalability remain decisive issues. Singapore’s Ministry of Sustainability and the Environment reported in February 2026 that the global alternative-protein industry, including cultivated meat, has faced challenges related to high production costs and weaker-than-expected consumer acceptance. Singapore nevertheless continues supporting research and commercialization, including SFA-backed research and development projects.

Regional Analysis

North America is identified by Next Move Strategy Consulting as the dominant regional market and is expected to maintain that position throughout the forecast period. The report connects the region’s position with urbanization, biotechnology activity and interest in alternative food production systems.

Asia-Pacific is expected to experience steady growth as biotechnology capabilities, bioprocessing infrastructure and government support for food innovation develop across the region. The report highlights China, Japan, India, South Korea, Australia, Singapore and other Asian markets as important parts of the regional landscape.

Singapore provides an example of active regulatory and research support. Its government reported in February 2026 that the Singapore Food Agency had awarded S$64 million to 21 multi-year projects since 2024 under the RIE2025 framework to build capabilities in alternative-protein process development, nutrition and functionality.

Industry and Competitive Landscape

The competitive landscape includes BlueNalu, Meatable, Aleph Farms, Vow, Mosa Meat, Steakholder Foods, Eat Just, Orbillion Bio, CellX, Finless Foods, BioCraft Pet Nutrition, SuperMeat, Upside Foods, Bluu Seafood and Aqua Cultured Food, among others. The Next Move Strategy Consulting report describes collaboration, product launches and research partnerships as important competitive strategies.

Industry development is increasingly tied to partnerships with research institutions and food regulators. Next Move Strategy Consulting cites a 2024 collaboration between Neat Meatt Biotech and India’s ICAR-Central Marine Fisheries Research Institute to support cultured-meat production research.

“The lab-grown food market is moving into a more practical phase in which scientific validation, production economics and regulatory readiness are becoming as important as cell-cultivation breakthroughs. The companies that can combine scalable bioprocessing with consistent product quality and clear consumer communication will be better positioned as additional markets develop regulatory pathways,” said a spokesperson at Next Move Strategy Consulting.

Market Report Overview

The Lab-Grown Food Market report from Next Move Strategy Consulting analyzes the industry from 2025 to 2030, covering market drivers, restraints, opportunities, trends, regional developments and competitive dynamics. The study segments the market by product type, source of cultivation, production technology, distribution channel, end consumer and region. Product categories include cultured meat, dairy alternatives, lab-grown egg products, and lab-grown gelatin and collagen. Production technologies include scaffold-based, suspension-based and bioreactor-based cultivation.

 

About Next Move Strategy Consulting

Next Move Strategy Consulting is a market research and consulting company providing market intelligence, industry analysis, competitive insights, and strategic research across a wide range of industries and geographic markets.

As regulatory approvals expand and developers continue working to improve scale, cost and product quality, the lab-grown food industry warrants close attention from food manufacturers, biotechnology companies, investors, retailers, technology providers and policymakers. Continued progress in cellular agriculture, bioreactor engineering, food safety assessment and consumer acceptance will determine how quickly these products move from early commercial applications toward broader food-market participation.